News and Insights
Healthcare law and policy is the heart of our work at Olsson Frank. Our deep understanding of the U.S. healthcare regulatory environment allows our team to both protect and advance the interests of our healthcare industry clients.
Recommended Strategy for Importers on 2025 IEEPA Tariff Refunds
On December 15, 2025, the U.S. Court of International Trade (CIT) issued a pivotal decision affecting importers seeking refunds of tariffs imposed under the International Emergency Economic Powers Act ...
Read More → 
President Trump’s Executive Order (EO), “Increasing Medical Marijuana And Cannabidiol Research,” May Benefit The Cannabis Industry, But Alone, Does Not Reschedule Marijuana
Today, President Trump signed an Executive Order (EO), Increasing Medical Marijuana and Cannabidiol Research. While the EO is being widely hailed as a significant advancement ...
Read More → 
CF‑28/29 Enforcement: What Importers Are Seeing Now on IEEPA and Steel/Aluminum Tariffs
In recent months, there has been a noticeable shift in how U.S. Customs and Border Protection (CBP) is handling Requests for Information (CF‑28) and Notices ...
Read More → 
Navigating the IEEPA Tariff Challenges— Preserve Your Rights to Potential IEEPA-Based Tariff Refunds
The ongoing court challenges to tariffs imposed under the International Emergency Economic Powers Act (IEEPA) are creating uncertainty for many U.S. importers. Recent federal court rulings have ...
Read More → 
November Food and Agriculture Regulatory Recap
OFW’s Food & Agriculture team regularly monitors announcements and policy issuances from FDA, USDA, and other agencies to keep our clients apprised of regulatory developments ...
Read More → 
CANNASWEEP
October & November 2025 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. ...
Read More →